Compare IDEXX Laboratories, Inc. (IDXX) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs United Parcel Service Inc — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while United Parcel Service Inc trades at $116 (market cap $96.18B). The key difference: United Parcel Service Inc is far larger — about 2.2× IDEXX Laboratories, Inc.'s market cap, and United Parcel Service Inc pays a 5.8% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | UPS | |
|---|---|---|
Market Cap | $44.48B | $96.18B |
Sector | Health | Industrials |
52-Week High | $766.68 | $120.00 |
52-Week Low | $520.87 | $82.58 |
Enterprise Value | $45.38B | $119.04B |
Volume | — | 2,288,643 |
Dividend Yield | — | 5.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
UPS stock trades at $116.34, down 1.17% on the day, with a bullish technical signal from moving averages and neutral oscillators. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 results due July 28, 2026. Revenue declined to $88.66 billion in 2025, but cost controls supported a net margin of 5.94% and strong ROE of 33.41%. The company maintains solid cash flow from operations of $8.45 billion and recently paid a $1.64 dividend.
Outlook is mixed: cost-cutting and potential Q2 earnings beat offer upside, but revenue pressure and Amazon's logistics expansion pose risks. Analysts are cautiously optimistic with a $112 consensus target, slightly below current price. Key investor focus is on Q2 results and updated guidance for second-half 2026 inflection point prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
